This post was originally published on this site
Meanwhile, the rapid spread of the highly infectious COVID-19 Delta variant has rekindled investors’ interest in the healthcare industry. This, along with the rising demand for therapeutics, rapid adoption of virtual health and digital innovations, and the aging population, should continue to drive the industry’s growth. In addition, increasing government support to improve healthcare infrastructure is further anticipated to propel the industry’s growth. Investors’ interest in healthcare stocks is evident in the Vanguard Health Care ETF’s (VHT) 7.7% returns over the past three months.
Because the healthcare industry tends to be non-cyclical, we believe quality healthcare stocks on the Dow Jones Index—Johnson & Johnson (JNJ), UnitedHealth Group Incorporated (NYSE:UNH), Merck & Co. Inc. (MRK), and Amgen Inc . (NASDAQ:AMGN)—could be best bets now.
